Shicheng Su
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
NCT Number: NCT06024187
The purpose of this study is to analyze whether cold dissection can decrease the rate of ischemia necrosis and other complications and then increase the aesthetic outcomes compared to electrocautery. The purpose of this study is to analyze whether cold dissection can decrease the rate of ischemia necrosis and other complications and then increase the aesthetic outcomes compared to electrocautery.
Interested in participating?
Request Info18 year–75 year
Female
Interventional
Not applicable
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
Breast cancer is the most common cancer among women in the world. Although breast-conserving surgery is a viable option for patients, mastectomy remains the choice of treatment. Despite oncologic and surgical safety of nipple-sparing mastectomy(NSM) with immediate breast reconstruction(IBR) were amply demonstrated, a number of acute and late complications can occur. Surgical technique may play a role in the postoperative outcomes of mastectomy skin flap.Previous studies suggest that cold dissection with scissors or scalpel, may lead to decreasing blood loss and rates of skin necrosis, compared to electrocautery. A retrospective study by Troy Ng demonstrated that the use of cold dissection is likely to decrease the rate of partial-thickness necrosis (13.0%→33.3%, p=0.01) and full-thickness necrosis (1.3%→12.8%, p=0.02). The purpose of this study is to analyze whether cold dissection can decrease the rate of ischemia necrosis and other complications and then increase the aesthetic outcomes compared to electrocautery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The subcutaneous flap dissection was performed with a scissor in this group. The boundary of mastectomy flap was defined as the edge of clavicle superiorly, the edge of sternum medially, the edge of inframammary fold inferiorly, and the edge of the latissimus dorsi laterally. Our tumescent technique utilizes a solution made by mixing 0.2ml of epinephrine with 250 ml of 0.9% Sodium Chloride solution to create a 1‰ ratio. 150ml to 150ml of the solution was injected into the subcutaneous tissue of the operated breast with a 20-gauge spinal needle to establish a bloodless plane. The septa between the skin flap and parenchyma then was dissected using a scissor.
The subcutaneous flap dissection was performed with electrocautery in this group. The boundary of mastectomy flap was defined as the edge of clavicle superiorly, the edge of sternum medially, the edge of inframammary fold inferiorly, and the edge of the latissimus dorsi laterally.
Time frame: Within one month post operation
Necrosis complications included nipple-areolar complex (NAC) and skin flap necrosis. NAC/skin flap necrosis could present as minor superficial epidermolysis requiring local wound care only, or full-thickness necrosis with any exposure of acellular dermal matrix, muscle, implant, or with full-thickness eschar that required surgical reoperation of debridement and repair.
Time frame: Within 1 year post operation
Time frame: within one year post operation
the incidence of surgical-site infection will be compared between two groups
Time frame: within one year post operation
the incidence of seroma, hematoma, blister, implant capsular contracture, and implant loss will be compared between two groups
Time frame: Evaluated pre-operation, at the first month, at 2 months, 3 months, 6 months and 12 months.
Evaluated by patients and five surgeons. In this scale, breast fullness; nipple-areola complex, shape, and contour; scar appearance, size, and fullness; and overall breast appearance will be assessed.
Time frame: Evaluated pre-operation, at the first month, at 2 months, 3 months, 6 months and 12 months.
The modules included Satisfaction with Breasts, Psychosocial Wellbeing, Sexual Wellbeing, and Physical Wellbeing Chest, Surgeon, Medical Staff, Office Staff.
Time frame: Evaluated at the first day, second day, third day and the first week, second week.
Pain was assessed using a visual analogue scale(VAS), where 0 = no pain and 10 = worst possible pain.
Time frame: Immediate post operation
Defined as the time calculated from the skin incision to the end of wound closure
Time frame: Immediate post operation
Blood loss (ml) during operation was compared between groups
Time frame: within three days post operation
Total drain volume(ml) within three days post operation
Time frame: Within 2 weeks of operation.
Duration of hospital stay post operation(d) will be compared between two group.
Time frame: Immediate post operation
Mean mastectomy weight of patients will be compared between two groups.
Time frame: Immediate post operation
Size of implant will be compared between two groups.
Contact information is provided by the study sponsor or research team.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Other
Necrosis After Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Prospective Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07060807
Breast Diseases, Breast Neoplasms
Daphne, Alabama, United States
View Trial DetailsNCT06830720
Breast Diseases, Breast Neoplasms
Wiener Neustadt, Lower Austria, Austria
View Trial DetailsNCT06312176
Breast Diseases, Breast Neoplasms
Chandler, Arizona, United States
View Trial DetailsNCT06966700
Breast Diseases, Breast Neoplasms
Gilbert, Arizona, United States
View Trial Details